Ann Oncol -- Table of Contents (May 2006, 17 [Supplement 3])

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Contents: Volume 17, 2006 Supplement 3   [Index by Author]

       introduction

       abstracts

       indices

4th International Symposium on Targeted Anticancer Therapies (TAT 2006) 16-18 March, 2006: Amsterdam, The Netherlands. Editors: G. Giaccone & M.W. Lobbezoo

Find articles in this issue containing these words:
[Search ALL Issues]

Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

introduction:

: Editors:
Ann Oncol 17: iii1-iii2; doi:10.1093/annonc/mdl900 [PDF]

: TAT 2006 sponsors & grants
Ann Oncol 17: iii4; doi:10.1093/annonc/mdl901 [PDF]

: welcome to TAT 2006!
Ann Oncol 17: iii5; doi:10.1093/annonc/mdl902 [PDF]

: MDICT Task Force: Methodology for the Development of Innovative Cancer Therapies
Ann Oncol 17: iii6; doi:10.1093/annonc/mdl903 [PDF]

: committees
Ann Oncol 17: iii7; doi:10.1093/annonc/mdl904 [PDF]

: meeting schedule at a glance
Ann Oncol 17: iii8; doi:10.1093/annonc/mdl905 [PDF]

: meeting schedule, THURSDAY, MARCH 16, 2006
Ann Oncol 17: iii9; doi:10.1093/annonc/mdl906 [PDF]

: meeting schedule, FRIDAY, MARCH 17, 2006
Ann Oncol 17: iii10-iii14; doi:10.1093/annonc/mdl907 [PDF]

: meeting schedule, SATURDAY, MARCH 18, 2006
Ann Oncol 17: iii15-iii16; doi:10.1093/annonc/mdl908 [PDF]

abstracts:

: plenary session 1: opening and keynotes
Ann Oncol 17: iii17-iii19; doi:10.1093/annonc/mdl909 [PDF]

: plenary session 2: angiogenesis and vascular-targeting agents
Ann Oncol 17: iii20; doi:10.1093/annonc/mdl910 [PDF]

: plenary session 3: clinical trial design for targeted agents
Ann Oncol 17: iii21-iii22; doi:10.1093/annonc/mdl911 [PDF]

: plenary session 4: targeting apoptosis
Ann Oncol 17: iii23; doi:10.1093/annonc/mdl912 [PDF]

: plenary session 5: promising agents targeting downstream signalling pathways
Ann Oncol 17: iii24-iii25; doi:10.1093/annonc/mdl913 [PDF]

: plenary session 6: promising agents targeting membrane receptors
Ann Oncol 17: iii26-iii27; doi:10.1093/annonc/mdl914 [PDF]

: plenary session 7: immunological targets and mechanisms
Ann Oncol 17: iii28-iii29; doi:10.1093/annonc/mdl915 [PDF]

: plenary session 8: new technologies and new approaches to targeted cancer therapy
Ann Oncol 17: iii30; doi:10.1093/annonc/mdl916 [PDF]

: plenary session 11: miscellaneous agents: preclinical and clinical studies
Ann Oncol 17: iii31-iii33; doi:10.1093/annonc/mdl917 [PDF]

: poster session 1: new drug targets, drug design and drug discovery
Ann Oncol 17: iii34-iii36; doi:10.1093/annonc/mdl918 [PDF]

: poster session 2: preclinical drug profiling
Ann Oncol 17: iii37-iii41; doi:10.1093/annonc/mdl919 [PDF]

: poster session 3: molecular diagnosis, patient selection and prognosis
Ann Oncol 17: iii42-iii46; doi:10.1093/annonc/mdl920 [PDF]

: poster session 4: vaccines, monoclonal antibodies and other immunotherapies
Ann Oncol 17: iii47-iii48; doi:10.1093/annonc/mdl921 [PDF]

: poster session 5: phase I and II studies of new agents
Ann Oncol 17: iii49-iii50; doi:10.1093/annonc/mdl922 [PDF]

: poster session 6: post-registration clinical research
Ann Oncol 17: iii51-iii52; doi:10.1093/annonc/mdl923 [PDF]

indices:

: subject index
Ann Oncol 17: iii53-iii54; doi:10.1093/annonc/mdl924 [PDF]

: author index
Ann Oncol 17: iii55-iii57; doi:10.1093/annonc/mdl925 [PDF]

Annals of Oncology

introduction:

abstracts:

indices: